Enovis Corp
ENOV22.590USD
+0.800+3.67%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
1.29BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Enovis Corp Unternehmen
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Enovis Corp Informationen
BörsenkürzelENOV
Name des UnternehmensEnovis Corp
IPO-datumMay 08, 2008
CEOMcdonald (Damien)
Anzahl der mitarbeiter7367
WertpapierartOrdinary Share
GeschäftsjahresendeMay 08
Addresse2711 Centerville Road
StadtWILMINGTON
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl19808
Telefon13022529160
Websitehttps://www.enovis.com/
BörsenkürzelENOV
IPO-datumMay 08, 2008
CEOMcdonald (Damien)
Führungskräfte von Enovis Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
113.85K
-666.00%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
35.79K
-325.00%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+6598.00%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+6598.00%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+6598.00%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
10.52K
+6598.00%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
10.52K
+6598.00%
Mr. A. Clayton Perfall
Mr. A. Clayton Perfall
Independent Director
Independent Director
--
--
Mr. Brady R. Shirley
Mr. Brady R. Shirley
Director
Director
--
--
Mr. Bradley J. (Brad) Tandy, J.D.
Mr. Bradley J. (Brad) Tandy, J.D.
Senior Vice President, Chief Legal Officer
Senior Vice President, Chief Legal Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
113.85K
-666.00%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
35.79K
-325.00%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+6598.00%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+6598.00%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+6598.00%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
10.52K
+6598.00%
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
International Reconstructive
128.99M
23.50%
U.S. Reconstructive
128.98M
23.50%
U.S. Bracing & Support
126.98M
23.13%
International P&R
92.55M
16.86%
U.S. Other P&R
71.41M
13.01%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
International Reconstructive
128.99M
23.50%
U.S. Reconstructive
128.98M
23.50%
U.S. Bracing & Support
126.98M
23.13%
International P&R
92.55M
16.86%
U.S. Other P&R
71.41M
13.01%
Aktionärsstatistik
Aktualisiert: Fri, Jan 16
Aktualisiert: Fri, Jan 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.92%
The Vanguard Group, Inc.
11.19%
American Century Investment Management, Inc.
8.27%
Dimensional Fund Advisors, L.P.
4.86%
Rubric Capital Management LP
4.81%
Andere
56.95%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.92%
The Vanguard Group, Inc.
11.19%
American Century Investment Management, Inc.
8.27%
Dimensional Fund Advisors, L.P.
4.86%
Rubric Capital Management LP
4.81%
Andere
56.95%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
62.74%
Investment Advisor/Hedge Fund
29.50%
Hedge Fund
16.32%
Research Firm
4.93%
Individual Investor
1.67%
Bank and Trust
1.23%
Pension Fund
1.01%
Sovereign Wealth Fund
0.05%
Family Office
0.04%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
617
68.12M
125.63%
--
2025Q3
641
68.12M
128.26%
-1.19M
2025Q2
651
69.44M
130.24%
+2.07M
2025Q1
629
67.38M
125.09%
-4.06M
2024Q4
625
63.48M
125.04%
+1.28M
2024Q3
599
62.09M
124.13%
-57.94K
2024Q2
602
61.71M
121.92%
+2.05M
2024Q1
635
59.58M
125.47%
-9.23M
2023Q4
647
58.62M
120.02%
+2.97M
2023Q3
636
55.66M
121.59%
+429.23K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
7.96M
13.92%
-55.88K
-0.70%
Sep 30, 2025
The Vanguard Group, Inc.
6.49M
11.35%
+120.78K
+1.90%
Sep 30, 2025
American Century Investment Management, Inc.
4.73M
8.27%
-6.26K
-0.13%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.97M
5.2%
+51.20K
+1.75%
Sep 30, 2025
Rubric Capital Management LP
2.75M
4.81%
+2.75M
--
Sep 30, 2025
Davenport Asset Management
2.81M
4.91%
+50.85K
+1.85%
Sep 30, 2025
Dorsey Asset Management LLC
2.40M
4.2%
-153.86K
-6.03%
Sep 30, 2025
State Street Investment Management (US)
2.35M
4.11%
-138.65K
-5.57%
Sep 30, 2025
Hood River Capital Management LLC
1.73M
3.02%
-7.30K
-0.42%
Sep 30, 2025
River Road Asset Management, LLC
1.44M
2.52%
+1.06K
+0.07%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
State Street SPDR S&P Health Care Equipment ETF
1.83%
Invesco S&P SmallCap Health Care ETF
1.09%
Invesco S&P SmallCap 600 Pure Value ETF
0.45%
State Street SPDR S&P 600 Small Cap Value ETF
0.25%
iShares S&P Small-Cap 600 Value ETF
0.24%
iShares U.S. Medical Devices ETF
0.21%
Humankind US Stock ETF
0.2%
State Street SPDR S&P SmallCap 600 ESG ETF
0.18%
Avantis US Small Cap Equity ETF
0.18%
Invesco S&P SmallCap 600 Revenue ETF
0.16%
Mehr Anzeigen
State Street SPDR S&P Health Care Equipment ETF
Anteil1.83%
Invesco S&P SmallCap Health Care ETF
Anteil1.09%
Invesco S&P SmallCap 600 Pure Value ETF
Anteil0.45%
State Street SPDR S&P 600 Small Cap Value ETF
Anteil0.25%
iShares S&P Small-Cap 600 Value ETF
Anteil0.24%
iShares U.S. Medical Devices ETF
Anteil0.21%
Humankind US Stock ETF
Anteil0.2%
State Street SPDR S&P SmallCap 600 ESG ETF
Anteil0.18%
Avantis US Small Cap Equity ETF
Anteil0.18%
Invesco S&P SmallCap 600 Revenue ETF
Anteil0.16%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Datum
Ex-Dividendentag
Art
Verhältnis
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
